Pfizer planning a wave of Phase 3 obesity trials

Pfizer is planning a wave of Phase 3 obesity trials, according to a report, as it looks to compete with Eli Lilly and Novo Nordisk in the obesity drug market.

Detected & updated continuously · Source: Nebula